ALIMERA SCIENCES
Alimera Sciences is a pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. The company is passionate about protecting the retina and developing innovative treatments to preserve vision.
ALIMERA SCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
2003-01-01
Address:
Alpharetta, Georgia, United States
Country:
United States
Website Url:
http://www.alimerasciences.com
Total Employee:
51+
Status:
Active
Contact:
+1 678 990 5740
Email Addresses:
[email protected]
Total Funding:
304.35 M USD
Technology used in webpage:
Amazon HSTS IPv6 Apple Mobile Web App Capable CloudFront GoDaddy SSL Elementor IIS 8 Elementor Pro Amazon Frankfurt Region
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
AOBiome
AOBiome is a life sciences company that focuses on transforming human health.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Ocumension Therapeutics
Ocumension Therapeutics investment in Post-IPO Equity - Alimera Sciences
Federal Government
Federal Government investment in Post-IPO Debt - Alimera Sciences
Deerfield
Deerfield investment in Post-IPO Equity - Alimera Sciences
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Alimera Sciences
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - Alimera Sciences
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Alimera Sciences
Palo Alto Investors
Palo Alto Investors investment in Post-IPO Equity - Alimera Sciences
Domain Associates
Domain Associates investment in Series C - Alimera Sciences
Polaris Partners
Polaris Partners investment in Series C - Alimera Sciences
Intersouth Partners
Intersouth Partners investment in Series C - Alimera Sciences
Key Employee Changes
Official Site Inspections
http://www.alimerasciences.com Semrush global rank: 646.91 K Semrush visits lastest month: 48.81 K
- Host name: cloudhost-63201.uk-south-2.nxcli.net
- IP address: 165.84.219.3
- Location: Byfleet United Kingdom
- Latitude: 51.3388
- Longitude: -0.474
- Timezone: Europe/London
- Postal: KT14
More informations about "Alimera Sciences"
ABOUT - Alimera Sciences Inc.
At Alimera we believe in finding a way to succeed in everything we do. We’re constantly inspired to find a way by being patient-centric, collaborative, motivated, resourceful and accountable.See details»
Alimera Sciences - Wikipedia
Alimera was founded in June 2003 by Dan Myers, Daniel White, Dave Holland and Mark Testerman. Three of the founders were previously part of Ciba Vision Ophthalmics, which was renamed Novartis Ophthalmics following a merger. In 2004, Alimera Sciences introduced Soothe emollient (lubricant) eye drops for people with dry eyes. Soothe was the first lubricant eye drop to feature Restoryl, a lipid restorative that works t…See details»
Alimera Sciences Company Profile | Management and Employees …
SQL International Organization for Standardization . HTML Web Hypertext Application Technology Working Group . Other Communication and Collaboration Software ...See details»
Alimera Sciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 678 990 5740 Alimera Sciences is a pharmaceutical company whose mission is to …See details»
Alimera Sciences Management Team | Org Chart - RocketReach
Alimerasciences.com; 2 44778574XXXX; 44176326XXXX; Mereena Kurien Quality Assurance System Manager at Alimera Sciences Lilburn, GA, US View. 1 alimerasciences.com; 3 …See details»
COMPANY HIGHLIGHTS - Alimera Sciences Inc.
In 2015, we launched ILUVIEN in the United States f or the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP). See …See details»
Alimera Sciences, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Alimera Sciences, Inc. of Alpharetta, GA. Get the latest business insights from Dun & Bradstreet.See details»
GOVERNANCE DOCUMENTS - Alimera Sciences
Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision …See details»
Working At Alimera Sciences: Company Overview and Culture
Alimerasciences.com. Organization Type. Public. Social Media. Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization …See details»
Alimera Sciences, Inc. - Drug pipelines, Patents, Clinical trials
Explore Alimera Sciences, Inc. with its drug pipeline, therapeutic area, technology platform, 15 clinical trials, 95 news, and 13 literature, Disease Domain:Endocrinology and Metabolic …See details»
IR Kit | Alimera Sciences Inc.
Scott Gordon, CORE IR [email protected]. Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned …See details»
Alimera Sciences - Overview, News & Similar companies - ZoomInfo
Jun 4, 2024 Alimera Sciences Reports First Quarter 2024 Results ATLANTA, May 14, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global …See details»
About - Alimera Sciences
Our vision. Our mission. Our Vision is for Alimera to be synonymous with good retinal health. We are a company of people with a passion for protecting the retina to preserve vision. People …See details»
Alimera - LinkedIn
Alimera | 10,530 followers on LinkedIn. We See More, Together™ | Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and …See details»
Alimera Sciences, Inc. - Cruelty Free Investing
Our Opinion. Alimera Sciences, Inc. is on the Cruelty Free Investing use of animals list because they conduct experiments on animal models. Company DescriptionSee details»
ALIMERA EXHIBITS CONTINUED GROWTH AND EXPANSION WITH …
Www.alimerasciences.com Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining …See details»
Alimera Sciences | UK
Adverse events should also be reported to Alimera Sciences: [email protected]. Report a compliance concern. You may report a …See details»
ANALYST COVERAGE - Alimera Sciences
Alimera Sciences Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Alimera Sciences Inc.'s performance made by these analysts …See details»
Alimera Sciences | Europe & the Middle East
European Headquarters Alimera Sciences Europe Ltd 77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin 2, D02 VK60, Ireland Tel: + 353 (0) 1 553 0215See details»